The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Behavior of Borderline Tumors With Particular Interest to Persistence, Recurrence, and Progression to Invasive Carcinoma: A Prospective Study
Abstract
PURPOSE: Borderline tumors account for 10% to 20% of epithelial ovarian tumors, and their prognosis is outstanding; nevertheless, a mortality of up to 20% has been reported, particularly in earlier reports. There is a lack of information about the actual mortality and the rate of progression into invasive carcinoma in large and prospectively accrued populations. PATIENTS AND METHODS: All women with borderline ovarian tumors undergoing primary surgery in our department or referred within 3 months from surgery performed elsewhere from 1982 to 1997 were prospectively accrued and observed. RESULTS: We studied 339 women (83.4% stage I, 7.9% stage II, and 8.5% stage III). The median age at diagnosis was 39 years. A total of 150 women underwent radical surgery, and 189 underwent fertility-sparing surgery. After surgery, 13 women had macroscopic residual disease. With a median follow-up of 70 months, 317 women are alive with no clinical disease (eight with documented subclinical persistence of implants), three are alive with clinical disease, two died of disease, 10 died of other reasons, and seven women have been lost to follow-up. The recurrence of disease was higher after fertility-sparing surgery (35 of 189 cases) than after radical surgery (seven of 150 cases); nevertheless, all but one woman with recurrence of borderline tumor or progression to carcinoma after conservative surgery were salvaged. We observed seven progressions (2.0%) into invasive carcinoma, five in serous tumors (2.4%), and two in mucinous tumors (1.6%). The disease-free survival is 99.6% in stage I patients, 95.8% in stage II, and 89% in stage III. CONCLUSION: The survival of patients with borderline tumors is higher than previously described in some retrospective studies. Conservative surgery is safe and may be proposed to several patients with early and disseminated disease after thorough discussion of all therapeutic options. Progression to carcinoma is approximately 2% and may be observed in both mucinous and serous tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical and histologic studies of ovarian carcinoma. Long-term follow-up of 990 cases.
Aure, J. C., Høeg, K., & Kolstad, P. (1971) · PubMed · Cited by 253
Ovarian serous borderline tumors with invasive peritoneal implants
Gershenson, D. M., Silva, E. G., Levy, L., Burke, T. W., Wolf, J. K., & Tornos, C. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980315)82:6<1096::aid-cncr13>3.0.co;2-1 · Cited by 203
Kennedy, A. W., & Hart, W. R. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960715)78:2<278::aid-cncr14>3.0.co;2-t · Cited by 175
Serous borderline tumors of the ovary with noninvasive peritoneal implants
Gershenson, D. M., Silva, E. G., Tortolero-Luna, G., Levenback, C., Morris, M., & Tornos, C. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19981115)83:10<2157::aid-cncr14>3.0.co;2-d · Cited by 173
Kærn, J., Tropé, C. G., & Abeler, V. M. (1993) · Cancer · doi:10.1002/1097-0142(19930301)71:5<1810::aid-cncr2820710516>3.0.co;2-v · Cited by 166
The Behavior of Serous Tumors of Low Malignant Potential
Kurman, R. J., & Trimble, C. L. (1993) · International Journal of Gynecological Pathology · doi:10.1097/00004347-199304000-00006 · Cited by 161
Serous ovarian tumors of low malignant potential with peritoneal implants
Gershenson, D. M., & Silva, E. G. (1990) · Cancer · Cited by 138
Borderline tumors of the ovary: correlation of frozen and permanent histopathologic diagnosis
Houck, K. P. (2000) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(99)00656-0 · Cited by 134
Ovarian surface epithelial-stromal tumors
Bell, D. A. (1991) · Human Pathology · doi:10.1016/0046-8177(91)90205-4 · Cited by 89
Cited by
Practice Bulletin No. 183: postpartum hemorrhage
(2017) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002351 · Cited by 1,406
Colombo, N., Sessa, C., du Bois, A., Ledermann, J., McCluggage, W. G., McNeish, I., Morice, P., Pignata, S., Ray-Coquard, I., Vergote, I., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz062 · Cited by 1,197
Colombo, N., Sessa, C., Bois, A. D., Ledermann, J., McCluggage, W., McNeish, I., Morice, P., Pignata, S., Ray-Coquard, I., Vergote, I., et al. (2019) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-2019-000308 · Cited by 407
Levine, D., Brown, D. L., Andreotti, R. F., Benacerraf, B., Benson, C. B., Brewster, W. R., Coleman, B., DePriest, P., Doubilet, P. M., Goldstein, S. R., et al. (2010) · Radiology · doi:10.1148/radiol.10100213 · Cited by 360
Longacre, T. A., McKenney, J. K., Tazelaar, H. D., Kempson, R. L., & Hendrickson, M. R. (2005) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000164030.82810.db · Cited by 323
Metadata
- Authors
- Zanetta, G., Rota, S., Chiari, S., Bonazzi, C., Bratina, G., & Mangioni, C.
- Venue
- Journal of Clinical Oncology
- Published
- 2001-05-15
- Volume
- 19
- Issue
- 10
- Pages
- 2658-2664
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1792540577
- Cited by
- 420
- References
- 9
- FWCI
- 10.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Behavior of Borderline Tumors With Particular Interest to Persistence, Recurrence, and Progression to Invasive Carcinoma: A Prospective Study. https://app.cochat.ai/papers/10.1200/jco.2001.19.10.2658
- The paper
- Zanetta, G., Rota, S., Chiari, S., Bonazzi, C., Bratina, G., & Mangioni, C. (2001). Behavior of Borderline Tumors With Particular Interest to Persistence, Recurrence, and Progression to Invasive Carcinoma: A Prospective Study. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2001.19.10.2658
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.